AP4E1
protein-codingadaptor related protein complex 4 subunit epsilon 1, the group of Clathrin/coatomer adaptor, adaptin-like, N-terminal domain containing|Adaptor related protein complex 4
Gene summary
This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~97.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013401
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0017241
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013401
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0100176
Submitter: ClinGen
AP4E1 loss-of-function variants have been reported in at least 21 individuals from 11 families with autosomal recessive Adaptor Protein 4 (AP4) deficiency syndrome (PMID: 32979048). AP4 deficiency results in severe early-onset developmental delay with motor delay and speech delay, intellectual disability, hypotonia in infancy followed by spastic paraplegia and later tetraplegia, microcephaly, and seizures (PMID: 32979048, 30543385). Biallelic AP4E1 nonsense, frameshift, splicing and large deletion variants leading to loss of AP4E1 protein function and the AP4 complex have been reported in AP4 deficiency syndrome patients (PMID: 32979048, 21620353, 20972249, 21937992, 23472171). The gene-disease association is further supported by biochemical and functional assays demonstrating loss of AP4 complex function and impaired protein trafficking in fibroblasts from patients with AP4E1 loss-of-function variants (PMID: 31915823). AP4E1 knockout mice demonstrate impaired motor coordination, weak grip strength, thin corpus callosum and impaired protein trafficking, which is consistent with features of AP4 deficiency syndrome (PMID: 29698489). In summary, the AP4E1 gene is definitively associated with autosomal recessive AP4 deficiency syndrome. This classification was approved by the Intellectual Disability and Autism Gene Curation Expert Panel on December 16, 2020. As of July 2024, this record underwent administrative updates to update scoring to be consistent with SOP Version 10.
Inheritance Pattern: AR
Disease ID:MONDO:0013401
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013401
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AP4E1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_007347.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 121 | 1 | 131 | ||
| missense | 1 | 320 | 23 | 1 | 345 | |
| nonsense | 6 | 2 | 8 | |||
| start loss | 1 | 1 | ||||
| frameshift | 7 | 11 | 1 | 19 | ||
| splice donor/acceptor (+/-2bp) | 1 | 7 | 3 | 2 | 13 | |
| Total | 14 | 21 | 334 | 146 | 2 | 517 |
Highest pathogenic variant AF is 0.000012391343
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_031373.2 | 21 | MANE Select | |
| Ensembl | ENSP00000261842.5 | 21 | MANE Select | |
| RefSeq | NP_001239056.1 | 19 | Standard | |
| Ensembl | ENSP00000452712.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lysosome - Homo sapiens (human)
- Golgi Associated Vesicle Biogenesis
- Lysosome Vesicle Biogenesis
- Clathrin derived vesicle budding
- trans-Golgi Network Vesicle Budding
Biological Process
- protein targeting
- protein localization
- vesicle-mediated transport
Molecular Function
- protein binding
Cellular Component
- AP-4 adaptor complex
- endosome lumen
- trans-Golgi network membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000261842
- Coding exons
- 21
- Length
- 97229
- Individuals with no LoFs
- 125662
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 86
- Defined
- 125748
- p
- 0.000342
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.521 | 532 | 567 | 0.938 | 0.0000260 | 7414 |
| Missense (PolyPhen) | 171 | 203.74 | 0.8393 | 2737 | ||
| Synonymous | -0.490 | 223 | 214 | 1.04 | 0.0000105 | 2162 |
| Loss of Function | 4.98 | 16 | 56.3 | 0.284 | 0.00000277 | 751 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00038 | 0.00038 | rare |
| South Asian | 0.00088 | 0.00088 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the adaptor protein complex 4 (AP-4). Adaptor protein complexes are vesicle coat components involved both in vesicle formation and cargo selection. They control the vesicular transport of proteins in different trafficking pathways (PubMed:10066790, PubMed:10436028). AP-4 forms a non clathrin- associated coat on vesicles departing the trans-Golgi network (TGN) and may be involved in the targeting of proteins from the trans-Golgi network (TGN) to the endosomal-lysosomal system. It is also involved in protein sorting to the basolateral membrane in epithelial cells and the proper asymmetric localization of somatodendritic proteins in neurons. AP-4 is involved in the recognition and binding of tyrosine-based sorting signals found in the cytoplasmic part of cargos, but may also recognize other types of sorting signal (Probable). {ECO:0000269|PubMed:10066790, ECO:0000269|PubMed:10436028, ECO:0000305|PubMed:10066790, ECO:0000305|PubMed:10436028}.;
- Disease
- DISEASE: Stuttering, familial persistent 1 (STUT1) [MIM:184450]: A familial form of stuttering, a disturbance in the normal fluency and time patterning of speech, characterized by frequent repetitions or prolongations of sounds or syllables, and by interruptions of speech known as blocks. STUT1 inheritance is autosomal dominant. {ECO:0000269|PubMed:26544806}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0996
Intolerance Scores
- LoFtool
- 0.691
- RVIS EVS
- -0.66
- RVIS percentile EVS
- 16.07
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.639
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |